Altria will buy a 45% stake in the company at $1.8 billion, and would have the option to raise its stake to 55%.Even before Friday’s announcement from Altria, there were reports of Altria possibly eyeing Cronos.
"Investing in Cronos Group as our exclusive partner in the emerging global cannabis category represents an exciting new growth opportunity for Altria," said Howard Willard, Altria's CEO, in a statement.
Cigarette smoking is reportedly thinning out probably due to increased health-consciousness among consumers – something that might be an additional reason behind Altria's decision to diversify into the recreational marijuana space.
Altria also announced plans to stop producing its MarkTen and Green Smoke e-cigarettes and its Verve oral nicotine, citing regulatory concerns and financial performance of the brands.
However, no decision has been reached yet on any transaction, according to Cronos. The announcement comes shortly after some reports in the media cited anonymous sources in suggesting that Altria might want to acquire Cronos.
With Canada’s legalization of recreational use of marijuana, the Canadian cannabis industry is seeming to emerge as a lucrative opportunity for companies/investors.U.S. beverage company Constellation Brands Inc., for example, announced a $3.8 billion investment in Canada’s cannabis company Canopy Growth Corp. in August.
With a declining trend in cigarette smoking among U.S. consumers, Altria might be looking at options to diversify its business, and the cannabis space could potentially be one of the options.
One of the world's largest producers and marketers of tobacco, cigarettes and related products, Altria Group has initiated talks with Canadian cannabis producer Cronos for a likely takeover, as it seeks to diversify its business beyond traditional tobacco smokers.
According to Marijuana Business Daily, the total demand for marijuana including both legal and black-market sales is estimated to be around $52.5 billion, while the e-cigarette market is expected to grow to $6.6 billion in the US in 2018.
Cigarette sales in the US are on a continuous decline over the last few years, largely owing to older smokers dying and very few young people taking up smoking.However, shares of Cronos rose as much as 23% as the news hit the market, pushing Cronos Group's market cap close to $2 billion.
The news comes as Altria is also eyeing a significant minority stake in e-cigarette company, Juul, in-line with its diversification strategy.
Altria Group beat Q3 estimates of earnings-per-share (EPS) and revenue.Nu-Mark will sell only tobacco, menthol, and mint flavors of MarkTen and Green Smoke cig-a-likes until any further order from the FDA.
In an environment of increasingly health-conscious consumers and heightened health regulatory measures, Phillip Morris International seems to be tapering its cigarette business to focus more on healthier alternatives.
In 2018, the company plans to invest almost $600 million in reduced risk products (RRP’s) or low-risk smoking alternatives – which includes its smokeless cigarettes, iQOS.The regulatory body has made it mandatory for tobacco companies to use precautionary labels on cigarette packets, and is reportedly trying to have manufacturers to reduce nicotine to low levels in their cigarettes.
Aphria Inc., the Canadian cannabis company that has reportedly been in talks to receive an investment from tobacco giant Altria Group (MO), reported a first quarter profit of C$21.2 million, up from the C$15 million it reported in the same quarter last year.
In a news release, the company said its profit came to nine cents per diluted share compared with a profit of $0.10 per diluted share in the same quarter last year, when it had fewer shares outstanding. Aphria attributed its growth to investments in Liberty Health Sciences and Hiku Brands Co. Ltd., and an increase in fair value of biological assets caused by a production increase.
Although it has not confirmed or denied the rumors of Altria's investment, Aphria shares (traded on the Canadian TSE stock exchange) have been trading higher since the report and its profit announcement.
As the legalization of recreational pot draws nearer in Canada, tobacco giant Altria (MO) is reportedly in talks to take a piece of Leamington, Ontario-based Aphria (APHQF).
Reuters says that Altria may initially take a minority stake in the company with the option to become a majority owner later on.In response to the report, Aphria released the following statement: "Aphria Inc. today responded to a request from the Investment Industry Regulatory Organization of Canada regarding media reports suggesting the Company is engaged in discussions regarding a potential investment in Aphria.